| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/2003 | EP1317532A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 06/11/2003 | EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/11/2003 | EP1317527A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 06/11/2003 | EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 06/11/2003 | EP1317487A2 Caveolin peptides and their use as therapeutics |
| 06/11/2003 | EP1317486A1 Interferon-alpha induced gene |
| 06/11/2003 | EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 06/11/2003 | EP1317484A2 VARIANTS OF i PHLEUM PRATENSE /i ALLERGENIC PROTEINS |
| 06/11/2003 | EP1317483A2 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 06/11/2003 | EP1317479A2 Methods and compositions for diseases associated with amyloidosis |
| 06/11/2003 | EP1317478A2 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II |
| 06/11/2003 | EP1317477A2 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 06/11/2003 | EP1317474A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 06/11/2003 | EP1317472A1 17 human secreted proteins |
| 06/11/2003 | EP1317470A1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 06/11/2003 | EP1317469A1 21 human secreted proteins |
| 06/11/2003 | EP1317468A1 23 human secreted proteins |
| 06/11/2003 | EP1317419A1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 06/11/2003 | EP1317412A1 Compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317310A1 Use of serum response factor (srf) modulator for treating srf related diseases |
| 06/11/2003 | EP1317309A2 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
| 06/11/2003 | EP1317308A2 Reduction of the electrocardiographic ot interval |
| 06/11/2003 | EP1317289A2 High efficiency cardiac gene transfer |
| 06/11/2003 | EP1317288A2 Method and composition for treating tumors by selective induction of apoptosis |
| 06/11/2003 | EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 06/11/2003 | EP1317283A2 Tweak receptor agonists as anti-angiogenic agents |
| 06/11/2003 | EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 06/11/2003 | EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 06/11/2003 | EP1317277A2 Antifungal combination therapy |
| 06/11/2003 | EP1317276A2 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 06/11/2003 | EP1317275A1 Medicament comprising a dna sequence which codes for the rna-binding koc protein, and comprising a koc protein or a dna sequence of the koc promoter |
| 06/11/2003 | EP1317274A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 06/11/2003 | EP1317273A1 Use of il-6r/il-6 chimera in huntington's disease |
| 06/11/2003 | EP1317271A2 Therapeutic and cosmetic uses of heparanases |
| 06/11/2003 | EP1317265A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 06/11/2003 | EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease |
| 06/11/2003 | EP1317256A2 Pharmaceutical composition having modified carrier |
| 06/11/2003 | EP1317226A1 Treatment of human herpesviruses using hyperthermia |
| 06/11/2003 | EP1317186A1 Improved bioactive whey protein hydrolysate |
| 06/11/2003 | EP1261314A4 Methods using phytol to improve the appearance of skin and compositions for such methods |
| 06/11/2003 | EP1140993B1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 06/11/2003 | EP1133307B1 Use of a composition comprising soy protein, dietary fibres and a phytoestrogen compound in the prevention and/or treatment of pulmonary diseases |
| 06/11/2003 | EP1126874B1 Multicomponent meningococcal vaccine |
| 06/11/2003 | EP1114060B1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 06/11/2003 | EP1062349B1 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 06/11/2003 | EP0942749B1 Treatment of stress-induced skin disease by corticotropin releasing hormone (crh) antagonists and skin mast cell degranulation inhibitors |
| 06/11/2003 | EP0848755B1 Vegf-related protein |
| 06/11/2003 | EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 06/11/2003 | EP0673417B1 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL $g(b)-BARREL |
| 06/11/2003 | EP0662086B1 Protein l and hybrid proteins thereof |
| 06/11/2003 | EP0661997B1 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 06/11/2003 | EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use |
| 06/11/2003 | CN1423704A Process for producing tripeptides |
| 06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
| 06/11/2003 | CN1423699A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 06/11/2003 | CN1423697A Virulence genes and proteins and their use |
| 06/11/2003 | CN1423695A Antisense oligonucleotides |
| 06/11/2003 | CN1423693A Method for the production of vitamin A |
| 06/11/2003 | CN1423660A Antibodies |
| 06/11/2003 | CN1423659A Recombinant gelatins |
| 06/11/2003 | CN1423658A Modulation of human sodium channels in dorsal root ganglia |
| 06/11/2003 | CN1423657A Inter feron-alpha induced gene |
| 06/11/2003 | CN1423656A Lipopeptides as antibacterial agents |
| 06/11/2003 | CN1423655A Novel lipopeptides as antibacterial agents |
| 06/11/2003 | CN1423647A Beta-alanine derivatives and their use as receptor antagonists |
| 06/11/2003 | CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors |
| 06/11/2003 | CN1423565A 精子因子oscillogenin Sperm factor oscillogenin |
| 06/11/2003 | CN1423564A APLIDINE treatment of cancers |
| 06/11/2003 | CN1423563A Pancreatic stem cells and their use in transplantation |
| 06/11/2003 | CN1423559A Controlled-release compositions containing opioid agonist and antagonist |
| 06/11/2003 | CN1423555A 掩蔽味道的涂料组合物 Taste-masking coating composition |
| 06/11/2003 | CN1422959A Secondary lymphoid chemotactic factor SLC preparation method |
| 06/11/2003 | CN1422870A Fusional protein with intensified activity of internal red-blood-cell formation element |
| 06/11/2003 | CN1422869A Diphtherin-gonadoliberin chimeric protein |
| 06/11/2003 | CN1422868A Receptor targeting chimeric toxin with junctional sequence |
| 06/11/2003 | CN1422866A Effective renaturation liquid of human interferon inclusion body comprising D-sorbiol and renaturation method |
| 06/11/2003 | CN1422865A Effective renaturation liquid of recombinant human interon inclusion body and renaturation method |
| 06/11/2003 | CN1422864A Zinc finger protein and its antibody preparation and use |
| 06/11/2003 | CN1422620A Aerosol for treating poisoning by nitrogen oxide and its use and preparation method |
| 06/11/2003 | CN1111070C Medicinal composition for treating thyroidism |
| 06/11/2003 | CN1111069C Application of congeners of MIP of HHV8 for preventing and treating AIDS |
| 06/10/2003 | US6576793 β2-adrenergic receptor agonists |
| 06/10/2003 | US6576766 Signal transduction inhibitors, compositions containing them |
| 06/10/2003 | US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide |
| 06/10/2003 | US6576758 Nucleic acid constructs containing hybrid promoters |
| 06/10/2003 | US6576755 Beta-defensins |
| 06/10/2003 | US6576754 Genetically engineered nucleic acids; proteins, fusion proteins and active fragments stimulate leukocyte response |
| 06/10/2003 | US6576753 Genomic clone of given sequence; can use in diagnosing susceptibility to asthma |
| 06/10/2003 | US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 06/10/2003 | US6576750 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs |
| 06/10/2003 | US6576745 Human cystatin F antibodies |
| 06/10/2003 | US6576742 DNA sequence encoding a human imidazoline receptor and method for cloning the same |
| 06/10/2003 | US6576741 Of given amino acid sequence; can use in determining the presence of virulent bacteria in a sample and for vaccine compositions |
| 06/10/2003 | US6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor |
| 06/10/2003 | US6576671 Left ventricular dysfunction; 5,6-dihydroxy- or 5,6-diiso-butyroloxy-2-methylaminotetralin |
| 06/10/2003 | US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative |
| 06/10/2003 | US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 06/10/2003 | US6576650 No central nervous system side effects |
| 06/10/2003 | US6576648 Compound with growth hormone releasing properties |